Sharp to package Alnylam RNAi therapeutics for Europe at Belgian site

Alnylam Pharmaceuticals and Sharp agreed that Sharp's Hamont-Achel site in Belgium will package all Alnylam products across European countries. Alnylam describes it as its first significant international investment in Belgium.

“Sharp Belgium's Hamont-Achel site will be responsible for the packaging of all Alnylam's products across European countries.”pharmoutsourcing.com

• 1 source
• pharmoutsourcing.comAlnylam Partners with Sharp on Packaging RNAi Therapeutics for Europe | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract ServicesSep 25, 2020

Summarized from public sources; check the original articles before acting on it.